Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $48.0100 (-1.11%) ($48.0100 - $48.0100) on Tue. Feb. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 26 | Latest Price | $48.0100(-1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -0.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(42%) XBI(42%) IFRA(40%) IWO(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.02% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-11%) GLD(-10%) BND(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.57(-7.17%) | Resistance Level | $50.11 | 5 Day Moving Average | $49.3(-2.62%) | 10 Day Moving Average | $49.32(-2.66%) | 20 Day Moving Average | $50.11(-4.19%) | To recent high | -19.1% | To recent low | 0% | Market Cap | $6.562b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |